CHD

Church & Dwight Co., Inc. (CHD) - Q3 2024 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly report (Form 10-Q) for Church & Dwight Co., Inc. for the period ended September 30, 2024. The company develops, manufactures, and markets consumer household and personal care products (e.g., ARM & HAMMER, OXICLEAN, WATERPIK, HERO) and specialty products. The quarter was significantly impacted by a strategic reassessment of its Vitamins, Minerals, and Supplements (VMS) business.

Key Financial Metrics

Material Changes vs. Prior Period

• Significant Impairment Charge: The company recorded a non-cash impairment charge of $357.1 million in Q3 2024 related to the VMS business (VITAFUSION and L'IL CRITTERS brands). This included a full impairment of the trade name ($281.3M), customer relationship intangibles ($15.8M), and PP&E ($60.0M). This charge turned Q3 operating income from a profit of $255.8M in 2023 to a loss of $91.5M in 2024.
• Revenue Growth: Net sales increased 3.8% in Q3 and 4.3% for the nine-month period, driven by volume growth (3.1% in Q3) and favorable pricing/mix (1.2% in Q3).
• Margin Expansion: Gross margin improved by 80 basis points in Q3 and 210 basis points for the nine-month period, aided by productivity programs, favorable pricing, and a $37.6M tariff refund from the U.S. government.
• Acquisitions and Divestitures: The company acquired Graphico, Inc. (Japan-based distributor) for $19.9M in June 2024. It also exited the MEGALAC supplement business and sold the Passport food safety business in 2024.

Guidance, Outlook, and Risks

• VMS Strategy Reassessment: Management is reassessing the long-term strategy for the VMS business due to declining market share and profitability driven by private label competition. Future cash flow estimates for this segment have been lowered.
• WATERPIK Risk: The WATERPIK trade name is under close monitoring. While it passed the annual impairment test in 2023, declining demand and consumer switching to value brands have eroded the excess fair value. A future impairment charge is possible if performance continues to deteriorate.
• Liquidity: The company maintains strong liquidity with $752.1M in cash and approximately $1,495M available through its revolving credit facility and commercial paper program. No share repurchases were made under the 2021 program in Q3 2024, leaving $658.9M of availability.
• Dividends: The quarterly dividend was increased to $0.28375 per share in Q1 2024.
• Capital Expenditures: Expected to be approximately $180.0M for 2024, primarily for manufacturing capacity investments.

Key Facts for Investor Verification

• Impairment Details: Verify the specific assumptions used in the VMS impairment analysis (discount rate of 8.25%, negative to low single-digit sales growth) and the remaining carrying value of VMS assets ($140.0M PP&E).
• WATERPIK Performance: Monitor upcoming quarterly results for WATERPIK sales trends and any indication of a triggering event for a potential goodwill or intangible impairment.
• Tariff Refund Impact: Confirm the sustainability of the $37.6M tariff refund benefit received in 2024 and its impact on future cost of goods sold.
• Debt Maturity: Note the repayment of the $200M term loan in Q1 2024; review the remaining debt schedule and interest coverage ratios.
• Private Label Competition: Assess the extent of market share loss in the VMS category to private label entrants and the effectiveness of management's response strategies.